Responder rate (achievement of at least 50% reduction in migraine frequency) Higher numbers mean more people responded · adults with migraine
It is very uncertain whether psychological therapies changes responder rate (achievement of at least 50% reduction in migraine… compared with controls (very low certainty).
1 finding from 1 review
Number of participants reporting an adverse event · adults with migraine
It is very uncertain whether psychological therapies changes adverse events (proportion of people reporting an adverse event)… compared with controls (very low certainty).
1 finding from 1 review
Fatigue · patients with fibromyalgia
Serotonin noradrenaline reuptake inhibitors showed no clear difference in self‐reported fatigue (20‐100 scale) Higher scores indicate higher… compared with placebo (low certainty).
1 finding from 1 review
Participant‐reported sleep problems (scale: 0 to 28; higher scores indicate more sleep problems) · patients with fibromyalgia
Serotonin noradrenaline reuptake inhibitors showed no clear difference in self‐reported sleep problems (0‐100 scale) Higher scores indicate… compared with placebo (low certainty).
1 finding from 1 review
Self‐reported health‐related quality of life (0‐100 scale) Higher scores indicate higher burden of disease (lower quality of life) · patients with fibromyalgia
Serotonin noradrenaline reuptake inhibitors showed no clear difference in self‐reported health‐related quality of life (0‐100 scale) Higher… compared with placebo (low certainty).
1 finding from 1 review
Participant‐reported sleep problems (scale: 0 to 28; higher scores indicate more sleep problems) · adults with fibromyalgia
Mirtazapine showed no clear difference in participant‐reported sleep problems (scale: 0 to 28; higher scores… compared with placebo (low certainty).
1 finding from 1 review
Intervention not reported
Health‐related quality of life (HRQOL), SD units: measured on FACIT‐Pal, TOI of FACT‐Hep, TOI of FACT‐L, FACT‐G, McGill Quality of Life, FACIT‐Sp. Higher scores indicate better HRQOL. · patients with advanced cancer
1 finding from 1 review
Intervention not reported
Depression, SD units: measured on CES‐D, HADS‐D, PHQ‐9. Higher scores indicate higher depressive symptom load. · patients with advanced cancer
1 finding from 1 review
Intervention not reported
Depression, natural units: measured on CES‐D (from 0 to 60). Higher scores indicate higher depressive symptom load · patients with advanced cancer
1 finding from 1 review
Intervention not reported
Symptom intensity, SD units: measured on ESAS, QUAL‐E Symptom Impact Subscale, SDS, RSC, LCS of FACT‐L, HCS of FACT‐Hep. Higher scores indicate higher symptom intensity. · patients with advanced cancer
1 finding from 1 review
Intervention not reported
Sleep problems (Scale 0 to 21; higher scores indicate more sleep problems) · adults with fibromyalgia
1 finding from 1 review
Intervention not reported
Pain end of treatment (0‐10 scale) Higher scores indicate higher pain levels · Patients with fibromyalgia
1 finding from 1 review
Health‐related quality of life end of treatment (0‐80 scale) Higher scores indicate lower health‐related quality of life · patients with fibromyalgia
1 finding from 1 review
Intervention not reported
Negative mood end of treatment (0‐10 scale) Higher scores indicate higher negative mood levels · Patients with fibromyalgia
1 finding from 1 review
Intervention not reported
Disability end of treatment (0‐10 scale) Higher scores indicate disability levels · Patients with fibromyalgia
1 finding from 1 review
Fatigue · patients with fibromyalgia
1 finding from 1 review
Participant‐reported sleep problems (scale: 0 to 28; higher scores indicate more sleep problems) · patients with fibromyalgia
1 finding from 1 review
Fatigue · patients with fibromyalgia
1 finding from 1 review
Participant‐reported sleep problems (scale: 0 to 28; higher scores indicate more sleep problems) · patients with fibromyalgia
1 finding from 1 review
Intervention not reported
Total studies: 42 Total participants: 14,626 · people with chronic pain Interventions: desvenlafaxine high dose (≥ 50 mg); duloxetine low dose (< 60 mg), standard dose (60 mg), and high…
The intervention led to lower total studies: 42 Total participants: 14,626; GRADE not reported.
1 finding from 1 review
no estimate extracted
42 participants
GRADE not reported